Barclays’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33K | Hold |
9,924
| – | – | ﹤0.01% | 4008 |
|
|
2025
Q1 | $15K | Hold |
9,924
| – | – | ﹤0.01% | 4093 |
|
|
2024
Q4 | $22K | Hold |
9,924
| – | – | ﹤0.01% | 4101 |
|
|
2024
Q3 | $25K | Sell |
9,924
-251
| -2% | -$632 | ﹤0.01% | 4037 |
|
|
2024
Q2 | $13K | Sell |
10,175
-15,618
| -61% | -$20K | ﹤0.01% | 3956 |
|
|
2024
Q1 | $75K | Sell |
25,793
-9,130
| -26% | -$26.5K | ﹤0.01% | 3732 |
|
|
2023
Q4 | $257K | Buy |
34,923
+26,744
| +327% | +$197K | ﹤0.01% | 3401 |
|
|
2023
Q3 | $63K | Buy |
8,179
+35
| +0.4% | +$270 | ﹤0.01% | 3492 |
|
|
2023
Q2 | $82K | Buy |
8,144
+2,927
| +56% | +$29.5K | ﹤0.01% | 3471 |
|
|
2023
Q1 | $51K | Sell |
5,217
-1,541
| -23% | -$15.1K | ﹤0.01% | 3780 |
|
|
2022
Q4 | $33K | Buy |
6,758
+2,168
| +47% | +$10.6K | ﹤0.01% | 3907 |
|
|
2022
Q3 | $65K | Buy |
4,590
+430
| +10% | +$6.09K | ﹤0.01% | 3573 |
|
|
2022
Q2 | $22K | Sell |
4,160
-3,068
| -42% | -$16.2K | ﹤0.01% | 4050 |
|
|
2022
Q1 | $47K | Buy |
+7,228
| New | +$47K | ﹤0.01% | 4025 |
|